Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Morphine on Dyspnea in PAH
NCT03401476Phase 2Unknown
- Start
- May 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of morphine in pulmonary arterial hypertension (PAH). Status: unknown.
02
Drugs
morphine
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03401476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401476.